Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

Healthcare Biotechnology
StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease... see more

Recent & Breaking News (TSX:SZLS)

GeneNews Publishes Data on ColonSentry® in Colorectal Cancer Risk Assessment

Canada NewsWire January 28, 2019

GeneNews Closes Funding for Second Convertible Security Funding Agreement with Lind Asset Management

Canada NewsWire January 11, 2019

GeneNews Expands Coverage by Commercial Health Insurance Networks

Canada NewsWire December 28, 2018

GeneNews Announces Q3 2018 Results and Provides Progress Update

Canada NewsWire November 15, 2018

GeneNews Announces Third Quarter 2018 Results Investor Call

PR Newswire November 13, 2018

Genmab and Seattle Genetics Announce Tisotumab Vedotin Data to Be Presented at ESMO 2018 Congress

Business Wire October 8, 2018

GeneNews Announces Resignation of Leslie Auld as CFO and Director and Appointment of Warren Whitehead as Chief Accountant.

Canada NewsWire September 24, 2018

GeneNews Announces Q2 2018 Results and Provides Progress Update

Canada NewsWire August 15, 2018

GeneNews and LifeX™ Partner to Deliver Proprietary "Liquid Biopsy" Molecular Diagnostics to Health Systems to Detect Cancer at Earliest Stages

Canada NewsWire August 15, 2018

/C O R R E C T I O N from Source -- GeneNews Limited/

Canada NewsWire August 13, 2018

GeneNews Second Quarter 2018 Operating and Financial Results

Canada NewsWire August 10, 2018

GeneNews' Innovative Diagnostic Laboratory Appoints David Byram Chief Commercial Officer

Canada NewsWire July 12, 2018

GeneNews Announces Election of Directors

Canada NewsWire June 29, 2018

GeneNews Early Warrant Exercise Incentive Program

Canada NewsWire June 14, 2018

GeneNews Closes on First Funding for Convertible Security Funding Agreement with Lind Asset Management

Canada NewsWire June 8, 2018

GeneNews Signs Convertible Security Funding Agreement with Lind Asset Management for up to $7.5 Million

Canada NewsWire June 1, 2018

GeneNews Announces Collaboration with AIM Laboratories to Expand Test Utilization

Canada NewsWire May 17, 2018

GeneNews Limited Closes First Tranche of Private Placement for Cdn$1.24 Million; Additionally Secures Agreement for US$500,000 Convertible Note

Canada NewsWire May 16, 2018

GeneNews Announces Q1 2018 Results and Provides Progress Update

Canada NewsWire May 16, 2018

GeneNews First Quarter 2018 Financial Results Conference Call - 8:00am Thursday, May 17, 2018

PR Newswire May 15, 2018